© 2003 by European Society of Cardiology
Copyright © 2003, European Society of Cardiology
Hereditary hemorrhagic telangiectasia: an update on transforming growth factor β signaling in vasculogenesis and angiogenesis
aHubrecht Laboratory, Netherlands Institute for Developmental Biology, Uppsalalaan 8, 3584 CT Utrecht, The Netherlands
bThe Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands
cSt. Antonius Hospital, Department of Pulmonary Disease, Nieuwegein, The Netherlands
* Corresponding author. Tel.: +31-30-212-1800; fax: +31-30-251-6464. christin{at}niob.knaw.nl
Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder in humans which has been mapped to two genes, endoglin and activin receptor-like kinase-1 (ALK-1) both of which mediate signaling by transforming growth factor β ligands in vascular endothelial cells. Animal models have shown that these receptors are not only important for maintaining vascular integrity but also for angiogenesis both during embryonic development and during tumor growth. Here, we review the current status of reported mutations in the context of the clinical manifestations and the effects on the vessel wall both in patients and in animal models of the disease.
KEYWORDS Angiogenesis; Growth factors; Receptors; Sequence (DNA/RNA/prot)
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Fonsatti, H. J.M. Nicolay, M. Altomonte, A. Covre, and M. Maio Targeting cancer vasculature via endoglin/CD105: a novel antibody-based diagnostic and therapeutic strategy in solid tumours Cardiovasc Res, October 30, 2009; (2009) cvp332v2. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Post, A. M. Smits, A. J. van den Broek, J. P.G. Sluijter, I. E. Hoefer, B. J. Janssen, R. J. Snijder, J. J. Mager, G. Pasterkamp, C. L. Mummery, et al. Impaired recruitment of HHT-1 mononuclear cells to the ischaemic heart is due to an altered CXCR4/CD26 balance Cardiovasc Res, October 8, 2009; (2009) cvp313v2. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. D. Upton, R. J. Davies, R. C. Trembath, and N. W. Morrell Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells J. Biol. Chem., June 5, 2009; 284(23): 15794 - 15804. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. F. Ramos, M. W. Lame, H. J. Segall, and D. W. Wilson Smad Signaling in the Rat Model of Monocrotaline Pulmonary Hypertension Toxicol Pathol, February 1, 2008; 36(2): 311 - 320. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lagna, M. M. Ku, P. H. Nguyen, N. A. Neuman, B. N. Davis, and A. Hata Control of Phenotypic Plasticity of Smooth Muscle Cells by Bone Morphogenetic Protein Signaling through the Myocardin-related Transcription Factors J. Biol. Chem., December 21, 2007; 282(51): 37244 - 37255. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Umans, L. Cox, M. Tjwa, V. Bito, L. Vermeire, K. Laperre, K. Sipido, L. Moons, D. Huylebroeck, and A. Zwijsen Inactivation of Smad5 in Endothelial Cells and Smooth Muscle Cells Demonstrates that Smad5 Is Required for Cardiac Homeostasis Am. J. Pathol., May 1, 2007; 170(5): 1460 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. V. Cohen, O. Kosti, and C. L. Stewart The nuclear envelope protein MAN1 regulates TGF{beta} signaling and vasculogenesis in the embryonic yolk sac Development, April 1, 2007; 134(7): 1385 - 1395. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. W. van Laake, S. van den Driesche, S. Post, A. Feijen, M. A. Jansen, M. H. Driessens, J. J. Mager, R. J. Snijder, C. J. J. Westermann, P. A. Doevendans, et al. Endoglin Has a Crucial Role in Blood Cell-Mediated Vascular Repair Circulation, November 21, 2006; 114(21): 2288 - 2297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Bangi and K. Wharton Dual function of the Drosophila Alk1/Alk2 ortholog Saxophone shapes the Bmp activity gradient in the wing imaginal disc Development, September 1, 2006; 133(17): 3295 - 3303. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z.M. Yan, Z.P. Fan, J. Du, H. Hua, Y.Y. Xu, and S.L. Wang A Novel Mutation in ALK-1 Causes Hereditary Hemorrhagic Telangiectasia Type 2 Journal of Dental Research, August 1, 2006; 85(8): 705 - 710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Jadrich, M. B. O'Connor, and E. Coucouvanis The TGF{beta} activated kinase TAK1 regulates vascular development in vivo. Development, April 1, 2006; 133(8): 1529 - 1541. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T G W Letteboer, J J Mager, R J Snijder, B P C Koeleman, D Lindhout, J K Ploos van Amstel, and C J J Westermann Genotype-phenotype relationship in hereditary haemorrhagic telangiectasia J. Med. Genet., April 1, 2006; 43(4): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Fernandez-L, F. Sanz-Rodriguez, F. J. Blanco, C. Bernabeu, and L. M. Botella Hereditary Hemorrhagic Telangiectasia, a Vascular Dysplasia Affecting the TGF-{beta} Signaling Pathway. Clin. Med. Res., March 1, 2006; 4(1): 66 - 78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Maio, M. Altomonte, and E. Fonsatti Is it the primetime for endoglin (CD105) in the clinical setting? Cardiovasc Res, March 1, 2006; 69(4): 781 - 783. [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Gu, P. Jin, L. Zhang, X. Zhao, X. Gao, Y. Ning, A. Meng, and Y.-G. Chen Functional analysis of mutations in the kinase domain of the TGF-beta receptor ALK1 reveals different mechanisms for induction of hereditary hemorrhagic telangiectasia Blood, March 1, 2006; 107(5): 1951 - 1954. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. B. McElhinney, J. Kreutzer, P. Lang, J. E. Mayer Jr, P. J. del Nido, and J. E. Lock Incorporation of the Hepatic Veins Into the Cavopulmonary Circulation in Patients With Heterotaxy and Pulmonary Arteriovenous Malformations After a Kawashima Procedure Ann. Thorac. Surg., November 1, 2005; 80(5): 1597 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Fernandez-L, F. Sanz-Rodriguez, R. Zarrabeitia, A. Perez-Molino, R. P. Hebbel, J. Nguyen, C. Bernabeu, and L.-M. Botella Blood outgrowth endothelial cells from Hereditary Haemorrhagic Telangiectasia patients reveal abnormalities compatible with vascular lesions Cardiovasc Res, November 1, 2005; 68(2): 235 - 248. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Enciso and K. K. Hirschi Understanding Abnormalities in Vascular Specification and Remodeling Pediatrics, July 1, 2005; 116(1): 228 - 230. [Full Text] [PDF]
|
|
|
|
|
|
S. Cambier, S. Gline, D. Mu, R. Collins, J. Araya, G. Dolganov, S. Einheber, N. Boudreau, and S. L. Nishimura Integrin {alpha}v{beta}8-Mediated Activation of Transforming Growth Factor-{beta} by Perivascular Astrocytes: An Angiogenic Control Switch Am. J. Pathol., June 1, 2005; 166(6): 1883 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Chen, J. L. Mehta, D. Li, L. Joseph, and J. Joseph Transforming Growth Factor {beta} Receptor Endoglin Is Expressed in Cardiac Fibroblasts and Modulates Profibrogenic Actions of Angiotensin II Circ. Res., December 10, 2004; 95(12): 1167 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A Karabegovic, M Shinawi, U Cymerman, and M Letarte No live individual homozygous for a novel endoglin mutation was found in a consanguineous Arab family with hereditary haemorrhagic telangiectasia J. Med. Genet., November 1, 2004; 41(11): e119 - e119. [Full Text] [PDF]
|
|
|
|
|
|
T. Seki, K.-H. Hong, J. Yun, S.-J. Kim, and S. P. Oh Isolation of a Regulatory Region of Activin Receptor-Like Kinase 1 Gene Sufficient for Arterial Endothelium-Specific Expression Circ. Res., April 30, 2004; 94(8): e72 - e77. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R E Harrison, J A Flanagan, M Sankelo, S A Abdalla, J Rowell, R D Machado, C G Elliott, I M Robbins, H Olschewski, V McLaughlin, et al. Molecular and functional analysis identifies ALK-1 as the predominant cause of pulmonary hypertension related to hereditary haemorrhagic telangiectasia J. Med. Genet., December 1, 2003; 40(12): 865 - 871. [Abstract] [Full Text] [PDF]
|
|